Brian Ganch is a freelance journalist. His interests are multifaceted and span from music (Bachelor of music performance in Percussion--performs in a Pennsylvania based Symphony Orchestra), to electronics, to biotechnology. He follows technology, music and entertainment, pharmaceutical and biotechology firms in the market place.
- United States Naval Academy, BS. Varsity Baseball. 9 Years active duty U.S. Naval Officer.
- University of Michigan Ross School of Business, MBA, Investment Finance
- Assistant Professor, University of Michigan.
- 19 years investment industry experience with traditional and alternative firms: Equity Analyst, Portfolio Manager, National Sales Manager, SVP, CIO.
My name is Payman Winborn. Upon graduation from college in 1999 I founded a company that distributed computer hardware. Although this was a profitable business, I did not want to focus all my resources on one avenue of success, so I looked to diversify my interests. I explored real estate and finance as possible alternative businesses and discovered an interest and passion in futures trading. This is what I ultimately choose as a second source of income.
Initially, I imagined that day trading would be the ideal profession: no customers or staff, no inventory or rent and the possibility of unlimited income. And, more importantly, it presented me with the opportunity to work anywhere....from the privacy of my home or from the balcony of a hotel room overlooking the Pacific Ocean.
Unfortunately, I knew little about the pitfalls of day trading for a living. To begin with, I spent countless hours reading books, studying charts and conducting research in an effort to become a profitable trader. Six years later, and after the loss of several hundred thousand dollars, my efforts finally resulted in the development of a highly profitable strategy.
This strategy is primarily based on technical analysis and was developed for ES E-Mini S&P 500 Futures contracts from CME Group but it also works in many other financial instruments such as Stocks (NYSE), Bonds, Currencies(Forex Spot), Commodities (Gold and Crude Oil From CME GROUP,Globex,NYMEX, CBOT,Brent Crud Oil From ICE Global Markets), Options, Global Indices and CFD’s with similar high accuracy.
In retrospect, I understand that the biggest barrier to my success was the fact that I tried to learn everything by myself. An experienced mentor could have helped me avoid that painful learning experience....and saved me a significant amount of money as well as many years of frustration.
Today I am an active, and profitable, trader. As a token of appreciation for my success, I now share my tools and experience with other day traders. I believe that my knowledge and skill can help others become successful traders and, in the summer of 2010, I began to publish my realtime market signals and daily results online in order to demonstrate the accuracy of my trading strategy.
I am a Financial Analyst and maintain my own Site http://www.everythingaboutinvestment.com where i put the articles regarding investment so that it can help each and everyone around the globe to get an detail insight into Investing and Investment.
Ian’s Insider Corner research focuses primarily on long-term dividend-paying companies with stable and reliable growth, stocks suitable for individual retirement accounts. Ian also looks for “niche” shorter-term trading opportunities, and coverage. During the 3-years Ian worked at Kerrisdale Capital, the New York-based activist hedge fund had great success exposing fraudulent companies. Kerrisdale Capital returned almost 200% in 2011, and more than 300% in total. Ian Bezek offers in-depth coverage of all the stocks in his “IMF” portfolio.
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began publishing in 2008, Garza has built a reputation as a writer and reporter who can move markets. His track record for accurately reporting rumors and alerting readers about developments in the biotech/healthcare sector is unmatched during that time.
Have been an investor for 60 years. Last 20 years have concentrated on biotechs. Have been senior exec with Shell and ITT before retiring 30+ years ago. My working areas were finance, informatics and international management. Taught MBA courses in management, informatics and communications. Speak French and Spanish plus some German.
Lee is the founder and managing director of Cell Therapy Group – a leading, boutique consultancy focused on the cell therapy and regenerative medicine industry.
Through CTG Lee works with companies of all sizes to help position them in the cell therapy regenerative medicine space by focusing on business development including strategy development, competitive intelligence, market research and analysis, deal-making, marketing and communications, profile-building, sale-lead generation, etc.
The core value Lee brings to CTG and its clients is a rare breadth of understanding of the entire spectrum of the cell therapy and regenmed industries primarily around who is doing what with whom. This knowledge of the industry players, what they have, and with whom they are working is both driven by and drives his proprietary industry database. Additionally, Lee leverages for his clients the relationships he has with executives in many of those companies and an extensive social media network.
Lee is also the co-founder, partner and Managing Director of RegenerativeMedicineJobs.com, an online job board and social recruiting system for employers and job seekers in the regenerative medicine industry.
Since early 2000, Lee has been an executive in the cell-based regenerative medicine industry. He has significant experience in both for-profit companies and non-profit organizations including Progenitor Cell Therapy, Malachite Management, Stem Cell Technologies, and the International Society for Cellular Therapy.
Before transitioning to biotech, Lee earned a law degree (cum laude) and was a practicing commercial attorney for several years.
Lee founded Cell Therapy News, created Cell Therapy Blog where he continues to blog, and serves on the editorial advisory boards of the journals BioProcess International and Regenerative Medicine.
Lee founded and served as Chair of ISCT's Cell Therapy Commercialization Committee (2006-9), founded and administers the LinkedIn Cell Therapy Industry Group, serves as an advisory board to the Student Society for Stem Cell Research (SSCR), and has served as an advisor to dozens of groups and projects in the regenerative medicine space.
Lee is a frequently invited speaker and moderator at conferences in the industry. He is also an invited guest blogger for the newly combined blog of the Canadian Stem Cell Network and the Canadian Centre for Regenerative Medicine (CCRM) entitled, “Signals”.
Recent publications include a book chapter entitled, “State of the Regenerative Medicine Industry” in The Delivery of Regenerative Medicines and Their Impact on Healthcare (CRC Press) and “Opportunities in Regenerative Medicine: The Global Industry and Market Trends” in BioProcess International, March 2011 Supplement. He has recently accepted an invitation to co-authored a book chapter entitled “Financing strategies for regenerative medicine production and technology development startups”.
Brian Ganch is a freelance journalist. His interests are multifaceted and span from music (Bachelor of music performance in Percussion--performs in a Pennsylvania based Symphony Orchestra), to electronics, to biotechnology.
He follows technology, music and entertainment, pharmaceutical and biotechology firms in the market place.